All News

Macleods Pharmaceuticals Limited has voluntarily recalled 1 lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer level, due to the detection of trace amounts of an unexpected impurity found in the product that is above the acceptable daily intake levels released by the FDA.

In the week ending Feb. 16, influenza was reported as widespread in 48 states and in Puerto Rico.

These products, from Mylan and Dr. Reddy’s Laboratories, are generic equivalents of Indivior PLC’s Suboxone sublingual film.1,2

Study explores the efficiency and accuracy of aspirin in colorectal cancer prevention.

Study highlights the importance of managing depression and anxiety to mitigate the effect on the cognitive function of patients with multiple sclerosis.

Top news of the week from Specialty Pharmacy Times.

The T cell marker could help lead the improved treatment for HIV and cancer patients.

The trial aimed to determine whether early intervention with Regeneron Pharmaceuticals' aflibercept injection (Eyelea) improved diabetic retinopathy severity and prevented serious vision-threatening complications.

Study findings also suggest a path forward to create even more effective flu vaccines.

Some may remember the old formulation of OTC Primatene Mist that was taken off the market in 2011 because it contained chlorofluorocarbon (CFC) propellants, which are known to deplete the ozone layer.

There is mixed evidence regarding the association between artificially sweetened beverages and the risk of cardiovascular disease adverse events.

Total Pharmacy™ is a unique platform to provide pharmacy professionals with the insight and resources to drive profitability while improving patient care.

Polypharmacy can contribute to a higher risk of health problems, such as drug interactions and adverse effects.

Translational study of breast cancer therapy sought to ‘take research from bench to bedside.’

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Longitudinal study of direct-acting antivirals for hepatitis C virus infection finds that treatment provides clinical benefit beyond virologic response, reducing risk for both all-cause mortality and for liver cancer.

High prices can negatively affect patient access and adherence.

A botanically-derived formula was found to heal cold sores in as little as 1 day.

The FDA’s acceptance of the application paves the way for an early review time.

Probiotics are misuderstood in their mechanisms of actions.

The new mobile app gives those with type 2 diabetes accurate insulin doses with an 'on-the-go' convenience.

Seladelpar would be indicated for patients with primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) who have an inadequate response to UDCA or as a monotherapy in adults unable to tolerate UDCA.

A Senzer medical device for delivering pharmaceutical-grade cannabinoids has been granted ISO certification for Design and Development.

The needed-free treatment option, ARS-1, is designed to be easy-to-use, convenient and more reliable than other emergency epinephrine treatments for severe allergic reactions.

Top news of the day across the health care landscape.

Top news of the day across the health care landscape.